Epigral

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE071N01016
  • NSEID: EPIGRAL
  • BSEID: 543332
INR
1,466.00
-10.5 (-0.71%)
BSENSE

Dec 05

BSE+NSE Vol: 11.96 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Epigral Ltd stock-summary
stock-summary
Epigral Ltd
Small Cap
Specialty Chemicals
Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products. The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 41.55 Cr
Number of Shares
4.16 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
20-May-2021
4.16
41.55
357044
10
Cancel. of Shares & Scheme of Arran
11-Feb-2019
4.12
41.19
-34566885
10
Cancellation of Shares
26-Apr-2018
7.58
75.76
5000000
10
further allotment
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 6 Schemes (4.74%)

FIIs

Held by 84 FIIs (2.71%)

Promoter with highest holding

Ashishbhai Natawarlal Soparkar (14.65%)

Highest Public shareholder

Hsbc Value Fund (3.49%)

Individual Investors Holdings

17.02%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Maulik Jayantibhai Patel
Chairman & Managing Director
6.15 cr
Kaushal Ashishbhai Soparkar
Managing Director
6.15 cr
Karana Rameshbhai Patel
Executive Director
3.85 cr
Ankit Natwarlal Patel
Executive Director
6.15 cr
Darshan Anandbhai Patel
Executive Director
2.7 cr
Manubhai Khodidas Patel
Independent Director
7.75 lacs
NIRALI BHAVIN PARIKH
Independent Director
7.0 lacs
Sanjay K Asher
Independent Director
4.0 lacs
Kanubhai S Patel
Independent Director
4.75 lacs
Raju Swamy
Independent Director
3.25 lacs
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
587 Cr
(Quarterly Results - Sep 2025)
Net Profit:
51 Cr
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 6,325 Cr (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.17%

stock-summary
Debt Equity

0.24

stock-summary
Return on Equity

19.15%

stock-summary
Price to Book

3.01